好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Combining MRI Activity with Markers of Myelin Damage in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis
MS and Related Diseases
(-)
107
Authors/Disclosures
Valentina Tomassini, MD (University G. d'Annunzio of Chieti-Pescara) No disclosure on file
Nicholas Calvo, MD (Carilion Clinic) No disclosure on file
No disclosure on file
Markus Reindl, PhD (Medical University of Innsbruck) The institution of Dr. Reindl has received research support from Euroimmun. The institution of Dr. Reindl has received research support from Roche.
Laura De Giglio No disclosure on file
Isabella Pestalozza No disclosure on file
Leslie West, MD (UCSF Neurology) Dr. West has nothing to disclose.
Patrizia Pantano Patrizia Pantano has nothing to disclose.
Philip H. Montenigro Mr. Montenigro has received personal compensation for serving as an employee of Arvinas. Mr. Montenigro has received personal compensation for serving as an employee of Eli Lilly. Mr. Montenigro has received personal compensation for serving as an employee of Biogen. Mr. Montenigro has stock in Biogen. Mr. Montenigro has received intellectual property interests from a discovery or technology relating to health care.
Thomas A. Berger, MD (Dept. of Neurology, Medical University of Vienna) Prof. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a speaker at scientific meetings and participant of local and international advisory boards with various companies producing and markerting treatments for multiple sclerosis (Almirall, Biogen, Biologix, Bionorica, Celgene-BMS, Merck, Novartis, Roche, Sanofi-Genzyme, TG Therapeutics, UCB).
Carlo Pozzilli Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.